SBIR Phase I: Enhanced Spectral Interferometry for Biological Imaging

SBIR 第一阶段：用于生物成像的增强型光谱干涉测量

• 批准号: 0214911
• 负责人: Daniel Kane
• 金额: $ 10万
• 依托单位: Southwest Sciences Inc
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2003-02-28
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0214911&HistoricalAwards=false
• 关键词: SBIR; Phase; Enhanced; Spectral; Interferometry

0214911KaneThis Small Business Innovation Research Phase I Project proposes to develop an enhanced spectral interferometry method for biological and biomedical applications. This method will provide rapid, high resolution optical imaging and can be easily coupled with fiber optics for in-vivo applications using endoscopes, catheters and similar devices. The Phase I Project will demontrate the utility of enhance spectral interferometry for cross-sectional imaging in biological tissues. In the follow on Phase II Project, a fiberoptic imaging spectral interferometer capable of high speed will be developed.The commercial applications of this project are in the area of biomedical devices and instrumentation. This technology will be applied to a variety of biomedical research and clinical needs including monitoring of tissue response to drugs or radiation exposure, detection of cancerous and pre-cancerous tissues, and the imaging of venous and arterial structures and ocular pathologies.

0214911凯恩这个小型企业创新研究第一阶段项目提议开发一种用于生物和生物医学应用的增强型光谱干涉测量方法。该方法将提供快速、高分辨率的光学成像，并且可以轻松地与光纤耦合，用于使用内窥镜、导管和类似设备的体内应用。第一阶段项目将展示增强光谱干涉测量技术在生物组织横截面成像中的实用性。后续二期项目将研发高速光纤成像光谱干涉仪。该项目的商业应用领域为生物医学设备和仪器仪表领域。该技术将应用于各种生物医学研究和临床需求，包括监测组织对药物或辐射暴露的反应、检测癌性和癌前组织、以及静脉和动脉结构和眼部病理的成像。